Beneficial effects of intra-arterial and intravenous prostaglandin E1 in intestinal ischaemia-reperfusion injury

Interactive Cardiovascular and Thoracic Surgery

Volumn 18, Issue 4, 2014, Pages 466-474

  García, Enrique María San Norberto ^a   Taylor, James Henry ^a   Cenizo, Noelia ^a   Vaquero, Carlos ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

Author keywords

Intestine; Ischaemia; Prostaglandin E1; Reperfusion injury

Indexed keywords

MYELOPEROXIDASE; PROSTAGLANDIN E1; PEROXIDASE; PROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; ENZYME ACTIVITY; HISTOPATHOLOGY; INTESTINE BLOOD FLOW; INTESTINE ISCHEMIA; INTESTINE MUCOSA; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SCORING SYSTEM; SUPERIOR MESENTERIC ARTERY; ANIMAL; CELL PROTECTION; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECTS; ILEAL DISEASES; ILEUM; IMMUNOLOGY; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MESENTERIC VASCULAR OCCLUSION; METABOLISM; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; TIME; VASCULARIZATION; WISTAR RAT;

ALPROSTADIL; ANIMALS; CYTOPROTECTION; DISEASE MODELS, ANIMAL; ILEAL DISEASES; ILEUM; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRA-ARTERIAL; MESENTERIC VASCULAR OCCLUSION; NEUTROPHIL INFILTRATION; NEUTROPHILS; PEROXIDASE; PROTECTIVE AGENTS; RATS; RATS, WISTAR; REPERFUSION INJURY; TIME FACTORS;

EID: 84896977345     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivt552     Document Type: Article

References (25)

1. Mallick IH, Yang W, Winslet MC, Seifalian AM. Ischemia-reperfusion injury of the intestine and protective strategies against injury. Dig Dis Sci 2004; 49:1359-77.
2. Linfert D, Chowdhry T, Rabb H. Lymphocites and ischemia-reperfusion injury. Transplant Rev (Orlando) 2009;23:1-10.
3. Milano PM, Douillet CD, Riesenman PJ, Robinson WP 3rd, Beidler SK, Zarzaur BL et al. Intestinal ischemia-reperfusion injury alters purinergic receptor expression in clinically relevant extraintestinal organs. J Surg Res 2008;145:272-8.
4. Von Scheidt W, Costard-Jaeckle A, Stempfle HU, Deng MC, Schwaab B, Haaff B et al. Prostagladin E1 testing in heart failure-associated pulmonary hypertension enables transplantation: the PROPHET study. J Heart Lung Transplant 2006;25:1070-6.
5. Huk I, Brovkovych V, Nanobashvili J, Neumayer C, Polterauer P, Prager M et al. Prostaglandin E1 reduces ischemia/reperfusion injury by normalizing nitric oxide and superoxide release. Shock 2000;14:234-42.
6. Blikslager AT, Pell SM, Young KM. PGE2 triggers recovery of transmucosal resistance via EP receptor cross talk in porcine ischemia-injured ileum. Am J Physiol Gastrointest Liver Physiol 2001;281:G375-81.
7. Blikslager AT, Roberts MC, Rhoads JM, Argenzio RA. Prostaglandins I2 and E2 have a synergistic role in rescuing epithelial barrier function in porcine ileum. J Clin Invest 1997;100:1928-33.
8. Kan T, Mitomi H, Saigenji K, Atari E. The effect of prostaglandin E1 and prostaglandin F2 alpha in the ischemic small intestine of dogs. Nihon Shokakibyo Gakkai Zasshi 1993;90:114-23.
9. Conde C, Herreros V, Rodríguez-Toves LA, Vaquero C. Effects of PGE1 on preservation of renal tissue after warm ischemia. Morphometric and histologic study. Spanish J Surg Res 2001;4:61-9.
10. Sketch MH Jr, Whelton A, Schollmayer E, Koch JA, Bernink PJ, Woltering F et al. Prostaglandin E1 Study Group. Prevention of contrast media-induced renal dysfunction with prostaglandin E1 a randomized, double-blind, placebo-controlled study. Am J Ther 2001;8:155-62.
11. Chiu CJ, McArdle AH, Brown R, Scott HJ, Gurd FN. Intestinal mucosal lesion in low-flow states: a morphological, hemodynamic and metabolic reappraisal. Arch Surg 1970;101:478-83.
12. Grisham MB, Hernandez LA, Granger DN. Xanthine oxidase and neutrophil infiltration in intestinal ischemia. Am J Physiol 1986;251:G567-74.
13. Naito Y, Takagi T, Yoshikawa T. Molecular fingerprints of neutrophildependent oxidative stress in inflammatory bowel disease. J Gastroenterol 2007;42:787-98.
14. Oltean M, Pullerits R, Zhu C, Blomgren K, Hallberg EC, Olausson M. Donor pretreatment with FK506 reduces reperfusion injury and accelerates intestinal graft recovery in rats. Surgery 2007;141:667-77.
15. Ioannou A, Dalle Lucca J, Tsokos GC. Immunopathogenesis of ischemia/reperfusion-associated tissue damage. Clin Immunol 2011;141:3-14.
16. Vollmar B, Menger MD. Intestinal ischemia/reperfusion: microcirculatory pathology and functional consequences. Langenbeks Arch Surg 2011;396: 13-29.
17. Kalogeris T, Baines CP, Krenz M, Korthuis RJ. Cell biology of ischemia/reperfusion injury. Int Rev Cell Mol Biol 2012;298:229-317.
18. Frishman WH, Novak S, Brandt LJ, Spiegel A, Gutwein A, Kohi M et al. Pharmacologic management of mesenteric occlusive disease. Cardiol Rev 2008;16:59-68.
19. Milio G, Cospite V, Cospite M. Effects of PGE1 in patients suffering from peripheral arterial occlusive disease. Minerva Cardioangiol 2003;51:311-6.
20. Ney P, Braun M, Szymanski C, Bruch L, Schrör K. Antiplatelet, antineutrophil and vasodilating properties of 13,14-dihydro-PGE1 (PGE0)-n in vivo metabolite of PGE1 in man. Eicosanoids 1991;4:177-84.
21. Krueger U, Scholz H, Heise M, Adeberg P, Petzold M, Zanow J et al. Effect of intravenous iloprost and alprostadil (PGE1) on peripheral resistance during femoro-distal reconstructions. Int Angiol 2000;19:358-65.
22. Gabriel A, Werba A, Mares P, Grubhofer G, Hrska F, Griesmacher A et al. Influence of prostaglandin E1 on tissue ischemia during surgical repair of the abdominal aorta. J Cardiothorac Vasc Anesth 1996;10:201-6.
23. Sako H, Hadama T, Miyamoto S, Anai H, Wada T, Iwata E et al. Effect of prostaglandin E1 on ischemia-reperfusion injury during abdominal aortic aneurysm surgery. Surg Today 2006;36:140-6.
24. Moeser AJ, Nighot PK, Engelke KJ, Ueno R, Blikslager AT. Recovery of mucosal barrier function in ischemic porcine ileum and colon is stimulated by a novel antagonist of the CIC-2 chloride channel, lubiprostone. Am J Physiol Gastrointest Liver Physiol 2007;292:G647-56.
25. Mallick IH, Winslet MC, Seifalian AM. Ischemic preconditioning of small bowel mitigates the late phase of reperfusion injury: heme oxygenase mediates cytoprotection. Am J Surg 2010;199:223-31.